Skip to content

Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study

Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05363553
Acronym
TIGER
Enrollment
146
Registered
2022-05-06
Start date
2022-05-25
Completion date
2024-08-28
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colic, Infantile, Constipation - Functional, Gastrointestinal Disorder, Functional, Infant Development, Regurgitation, Gastric

Keywords

infant formula, goat milk, regurgitation

Brief summary

To compare the frequency of regurgitation and other digestive outcomes between infants who receive an infant formula based on whole goat milk and an infant formula based on cow milk proteins during the transition period from breastfeeding to formula feeding, using predominantly breastfed infants as a reference group.

Detailed description

The study is a randomized, double-blind, parallel-group trial to study the effect of feeding infants goat milk or cow milk formula in the first 6 months of life on the prevalence of functional gastrointestinal disorders and other health outcomes, including gastrointestinal health and sleep during the transition from breastfeeding to formula-feeding. A predominantly breastfed group is used as a reference group.

Interventions

DIETARY_SUPPLEMENTInfant formula based on whole goat milk

Infant formula based on whole goat milk, nutritionally suitable for infants aged 0-6 months

DIETARY_SUPPLEMENTinfant formula based on cow milk proteins

Infant formula based on cow milk proteins, nutritionally suitable for infants aged 0-6 months

Sponsors

Chulalongkorn University
CollaboratorOTHER
Dairy Goat Co-operative (N.Z.) Limited
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Quadrupole

Intervention model description

Parallel assignment

Eligibility

Sex/Gender
ALL
Age
2 Weeks to 4 Months
Healthy volunteers
Yes

Inclusion criteria

* healthy full-term born infants (≥ 37 weeks + 0 days and \< 41 weeks + 6 days of gestation) * birth weight ≥ 2.5 kg and ≤ 4.5 kg * born from a singleton pregnancy * live in Bangkok or nearby with no plan for geographical migration before 6 months of age * for experimental and active comparator groups only: parent(s) has expressed the intention to partially (in combination with breastfeeding) or fully formula-feed the infant and ready to enroll in the study before the age of 4 months/120 days * for no intervention group only: parent(s) has expressed the intention to predominantly breastfeed (according to study definition) and ready to enroll in the study before the age of 4 months/120 days * infant has been predominantly breastfed for at least 2 weeks before enrollment * parent(s) has sufficient Thai language skills to understand the study information, the informed consent, and to comply with the study procedure * parent(s) is willing and deemed able to fulfil the requirements of the study protocol and procedures * at least one parent is of legal age of consent

Exclusion criteria

* infant has any disorder considered to interfere with nutrition, growth or development of the immune system * participation of the infant in any other interventional trial or participation of the mother in any intervention trial with infant follow-up * for experimental and active comparator groups only: infant has been formula-fed for more than 1 week before enrolment * for experimental and active comparator groups only: cow milk allergy or intolerance of the infant * for experimental and active comparator groups only: enrolled infant who never consumed any study product until the first visit 2 weeks following enrolment

Design outcomes

Primary

MeasureTime frameDescription
Change in daily frequency of regurgitation during the transition period from breastfeeding to formula feedingFrom Day 0 to Day 28Parental diary record of number of regurgitation per day reviewed at Day 0, Day 14 and Day 28

Secondary

MeasureTime frameDescription
Frequency of infant colicDay 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeksRome IV criteria diagnosed by physician
Frequency of functional constipationDay 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeksRome IV criteria diagnosed by physician
Stool consistencyDay 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeksStool consistency based on Brussels infants and toddler stool scale (BITSS)
Frequency of infant regurgitationDay 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeksRome IV criteria diagnosed by physician
Feeding difficultiesDay 0, Day 14, Day 28, and Age 8, 16 and 24 weeksNeoEAT questionnaire
SleepDay 0, Day 28, and Age 12 and 24 weeksBrief Infant Sleep questionnaire
Biochemical and metabolic markers: saliva markersDay 0 and Day 14Saliva: inflammation markers (including enzymes reported in U/mL)
Stool frequencyDay 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeksNumber of defecations per day

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026